Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(<i>N</i>-methyl-<i>N</i>-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols
作者:David B. Repke、Wilfred J. Ferguson、Dallas K. Bates
DOI:10.1002/jhet.5570180131
日期:1981.1
Structural alteration of the Nb-substituents of psilocin (3-[2-dimethylamino)ethyl]indol-4-ol) (12a) has led to a number of compounds containing known pharmacophoric groups. Further, it is hoped that the subtle changes in the nature of these substituents may lead to a clearer understanding of the structure-activity relationships of the 4-hydroxytryptamine hallucinogens.
psilocin(3- [2-二甲基氨基)乙基]吲哚-4-醇(12a)的N b-取代基的结构改变导致许多化合物含有已知的药效基团。此外,希望这些取代基的性质的细微变化可以导致对4-羟基色胺致幻剂的结构-活性关系的更清楚的理解。